RESUMEN
The present study demonstrated that intravenous injection of a high dose of compound 48/80 to the rat induced 50% drop, within a few min, in the mean arterial pressure and pulse pressure as well as systemic inflammatory plasma leakage that might lead to circulatory and respiratory failure. We also investigated whether pretreatment with Evans blue, a stimulator of BK(Ca) channels, could exert inhibitory effect against compound C48/80-induced allergic circulatory shock and systemic inflammation. Different groups of Sprague-Dawley rats received an intravenous injection of a dose of Evans blue (0, 5, 10, or 50 mg/kg) just 20 s prior to injection of compound 48/80 (200 µg/kg, over 2 min). The present study found that pretreatment with Evans blue in a dose of 10 or 50 mg/kg exerted acute inhibitory effect on compound 48/80-induced sudden drop in mean arterial and pulse pressures. We also showed that pretreatment with Evans blue in a dose of 5, 10, or 50 mg/kg significantly inhibited compound 48/80-induced extensive plasma extravasation, mast cell degranulation, and edema formation in various organs including the airways, esophagus, and skin. Pretreatment with Evans blue 50 mg/kg 1 h earlier exhibited longer-term inhibitory effect on compound 48/80-induced arterial hypotension and systemic inflammation. We concluded that Evans blue pretreatment prevented rats from compound 48/80-triggered allergic shock and systemic inflammation, possibly mainly through inhibition of mast cell degranulation. Evans blue might be potentially useful in elucidating the mechanism and acting as a therapeutic agent of allergic shock and systemic inflammation.
Asunto(s)
Azul de Evans/farmacología , Inflamación/prevención & control , Canales de Potasio de Gran Conductancia Activados por el Calcio/agonistas , Mastocitos/efectos de los fármacos , Choque/prevención & control , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , Animales , Antiinflamatorios/farmacología , Degranulación de la Célula/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Edema/inducido químicamente , Edema/prevención & control , Inflamación/inducido químicamente , Masculino , Ratas , Ratas Sprague-Dawley , Frecuencia Respiratoria/efectos de los fármacos , Choque/inducido químicamente , Vénulas/efectos de los fármacos , Vénulas/patología , p-Metoxi-N-metilfenetilamina/toxicidadRESUMEN
Aegeline or N-[2-hydroxy-2(4-methoxyphenyl) ethyl]-3-phenyl-2-propenamide is a main alkaloid isolated from Aegle marmelos Correa collected in Yogyakarta Indonesia. In our study, we investigated the effects of aegeline on the histamine release from mast cell. The study was performed by using (1) rat basophilic leukemia (RBL-2H3) cell line, and (2) rat peritoneal mast cells (RPMCs). DNP(24)-BSA, thapsigargin, ionomycin, compound 48/80 and PMA were used as inducers for histamine release from mast cell. In our study, aegeline inhibited the histamine release from RBL-2H3 cells induced by DNP(24)-BSA. Indeed, aegeline showed strong inhibition when RBL-2H3 cells induced by Ca(2+) stimulants such as thapsigargin and ionomycin. Aegeline is suggested to influence the intracellular Ca(2+) pool only since could not inhibit the (45)Ca(2+) influx into RBL-2H3 cells. Aegeline showed weak inhibitory effects on the histamine release from RPMCs, even though still succeed to inhibit when the histamine release induced by thapsigargin. These findings indicate that aegeline altered the signaling pathway related to the intracellular Ca(2+) pool in which thapsigargin acts. Based on the results, the inhibitory effects of aegeline on the histamine release from mast cells depended on the type of mast cell and also involved some mechanisms related to intracellular Ca(2+) signaling events via the same target of the action of thapsigargin or downstream process of intracellular Ca(2+) signaling in mast cells.
Asunto(s)
Aegle/química , Amidas/farmacología , Interacciones de Hierba-Droga , Liberación de Histamina/efectos de los fármacos , Mastocitos/efectos de los fármacos , Amidas/aislamiento & purificación , Animales , Calcio/metabolismo , Técnicas de Cultivo de Célula , Línea Celular Tumoral , Dinitrofenoles/antagonistas & inhibidores , Dinitrofenoles/farmacología , Ionomicina/antagonistas & inhibidores , Ionomicina/farmacología , Masculino , Mastocitos/metabolismo , Ratas , Ratas Wistar , Albúmina Sérica Bovina/antagonistas & inhibidores , Albúmina Sérica Bovina/farmacología , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Acetato de Tetradecanoilforbol/farmacología , Tapsigargina/antagonistas & inhibidores , Tapsigargina/farmacología , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
The mast cell-mediated immediate-type allergic reaction is involved in many allergic diseases such as asthma, allergic rhinitis, and sinusitis. Stimulation of mast cells starts the process of degranulation resulting in release of mediators such as histamine and an array of inflammatory cytokines. In this report, we investigated the effect of aqueous extract of Teucrium japonicum Houttuyn (Labiatae) (AXTJ) on the mast cell-mediated allergy model and studied its possible mechanisms of action. AXTJ inhibited compound 48/80-induced systemic reactions and serum histamine release in mice. AXTJ decreased immunoglobulin E-mediated passive cutaneous anaphylaxis reaction. AXTJ reduced histamine release and intracellular calcium from rat peritoneal mast cells activated by compound 48/80. In addition, AXTJ attenuated activation of nuclear factor (NF)-kappaB, and downstream tumor necrosis factor (TNF)-alpha expression in phorbol 12-myristate 13-acetate and calcium ionophore A23187-stimulated human mast cells. Our findings provide evidence that AXTJ inhibits mast cell-derived allergic reactions and involvement of intracellular calcium, TNF-alpha, and NF-kappaB in these effects.
Asunto(s)
Antialérgicos/farmacología , Antagonistas de los Receptores Histamínicos , Liberación de Histamina/efectos de los fármacos , Mastocitos/efectos de los fármacos , Extractos Vegetales/farmacología , Teucrium/química , Animales , Antialérgicos/química , Calcimicina/farmacología , Calcio/metabolismo , Células Cultivadas , Hipersensibilidad/tratamiento farmacológico , Ionóforos/farmacología , Mastocitos/metabolismo , FN-kappa B/metabolismo , Ésteres del Forbol/farmacología , Extractos Vegetales/química , Ratas , Factor de Necrosis Tumoral alfa/metabolismo , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
Green tea catechins are emerging as one of the most efficient and safest ingredient in health promoting food. We investigated catechin's effects on intracellular ROS generation in mast cell activation and degranulation. Compound 48/80, receptor mimetic basic secretagogues for mast cell, induced ROS generation dose-dependently with bell-shaped degranulation pattern in canine cutaneous mastocytoma cells (CM-MC). When intracellular ROS level was relatively low, catechins decreased both ROS and the degranulation. However, when intracellular ROS level was remarkably high, catechins decreased ROS level but increased the degranulation paradoxically. Gallocatechins showed the stronger effects than non-gallated catechins. Exogenous H(2)O(2) also shows dual effect on degranulation dose-dependently. EGCG shows the dual effect on the tyrosine and threonine phosphorylation depending on the concentration of compound 48/80. Particularly, 60 kDa protein tyrosine-phosphorylated by EGCG with 3 microg/ml of compound 48/80 might be a negative regulator for the degranulation. Taken together, there is an optimal level of ROS for the degranulation, and the catechins have a dual function by controlling ROS level.
Asunto(s)
Antioxidantes/farmacología , Catequina/farmacología , Degranulación de la Célula/efectos de los fármacos , Mastocitos/efectos de los fármacos , Té/química , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacología , Animales , Western Blotting , Calcio/metabolismo , Células Cultivadas , Perros , Relación Dosis-Respuesta a Droga , Peróxido de Hidrógeno/farmacología , Fosforilación , Proteínas Tirosina Quinasas/metabolismo , Especies Reactivas de Oxígeno/metabolismoRESUMEN
BACKGROUND: Basic secretagogues of connective tissue mast cells act as receptor mimetic agents that trigger mast cells by activating G proteins. This leads to simultaneous propagation of two signaling pathways: one that culminates in exocytosis, while the other involves protein tyrosine phosphorylation and leads to release of arachidonic acid metabolites. We have previously shown that introduction of a peptide that comprises the C-terminal end of G alpha i3 into permeabilized mast cells inhibits basic secretagogue-induced exocytosis [Aridor et al., Science 1993;262:1569-1572]. We investigated whether cell-permeable peptides, composed of the C-terminus of G alpha i3 fused with importation sequences, affect mast cell function. METHODS: Following preincubation with the fused peptides, rat peritoneal mast cells were activated by compound 48/80 and analyzed for histamine and prostaglandin D2 release and protein tyrosine phosphorylations. RESULTS: We demonstrate that out of three importation sequences tested only G alpha i3 peptide fused with the Kaposi fibroblast growth factor importation sequence (ALL1) inhibited release of histamine. ALL1 as well as a cell-permeable peptide that corresponds to G alpha i2 also blocked compound 48/80-stimulated protein tyrosine phosphorylation, though the latter did not block histamine release. ALL1 effect was G protein-specific, as it was incapable of blocking protein tyrosine phosphorylation stimulated by pervanadate. CONCLUSION: ALL1, a transducible G alpha i3-corresponding peptide, blocks the two signaling pathways in mast cells: histamine release and protein tyrosine phosphorylation. Cell permeable peptides that block these two signaling cascades may constitute a novel approach for preventing the onset of the allergic reaction.
Asunto(s)
Subunidades alfa de la Proteína de Unión al GTP Gi-Go/farmacología , Mediadores de Inflamación/fisiología , Mastocitos/efectos de los fármacos , Péptidos/farmacología , Secuencia de Aminoácidos , Animales , Permeabilidad de la Membrana Celular , Evaluación Preclínica de Medicamentos , Subunidad alfa de la Proteína de Unión al GTP Gi2/farmacología , Liberación de Histamina/efectos de los fármacos , Integrina beta3/química , Mastocitos/metabolismo , Datos de Secuencia Molecular , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/farmacología , Péptidos/síntesis química , Fosforilación/efectos de los fármacos , Prostaglandina D2/metabolismo , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Transducina/farmacología , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidoresRESUMEN
We investigated the effect of a herbal formulation Okbyungpoong-Gamhmi (OG) on mast cell-dependent anaphylactic reactions by intra-rectal administration. OG concentration dependently inhibited compound 48/80-induced anaphylaxis-like response and ear swelling response with doses of 0.01-1g/kg. OG also inhibited the passive cutaneous anaphylaxis at the same concentrations. The histamine release induced by compound 48/80 or IgE from the rat peritoneal mast cells was reduced by 64.2 and 63.6%, respectively, at 1g/l. These results provide evidence that intra-rectal therapy of OG may be beneficial in the treatment of anaphylactic response.
Asunto(s)
Anafilaxia/tratamiento farmacológico , Mastocitos/efectos de los fármacos , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Fitoterapia/métodos , Preparaciones de Plantas/uso terapéutico , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , Anafilaxia/inducido químicamente , Animales , Corea (Geográfico) , Masculino , Mastocitos/metabolismo , Medicina Tradicional , Ratones , Ratones Endogámicos ICR , Preparaciones de Plantas/aislamiento & purificación , Ratas , Ratas Sprague-Dawley , p-Metoxi-N-metilfenetilamina/efectos adversosRESUMEN
The effects of extracts from various oriental medicinal herbs on mast cell-mediated allergic reaction were investigated. Among them, Chrysanthemi sibirici herba ethanol extract exerted the potent inhibitory activity on antigen-induced degranulation in RBL-2H3 mast cells. Chrysanthemi sibirici herba dose-dependently inhibited DNP-BSA or compound 48/80-induced degranulation in RBL-2H3 mast cells, with IC(50) values of approximately 49 microg/ml and 76 microg/ml, respectively. This extract strongly suppressed compound 48/80-induced systemic anaphylaxis by 48.7% at a dose of 300 mg/kg in mice. Chrysanthemi sibirici herba also inhibited the expression of TNF-alpha and the activation of the MAP kinase, ERK1/2, which is critical for the production of inflammatory cytokines in mast cells, as indicated by the suppression of activating phosphorylation of ERK1/2. These results lead us to conclude that Chrysanthemi sibirici herba may be used clinically to treat various allergic diseases.
Asunto(s)
Anafilaxia/prevención & control , Chrysanthemum , Mastocitos/efectos de los fármacos , Preparaciones de Plantas/farmacología , p-Metoxi-N-metilfenetilamina/toxicidad , Anafilaxia/inducido químicamente , Animales , Degranulación de la Célula/efectos de los fármacos , Degranulación de la Célula/fisiología , Relación Dosis-Respuesta a Droga , Masculino , Mastocitos/metabolismo , Ratones , Ratones Endogámicos ICR , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Preparaciones de Plantas/aislamiento & purificación , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidoresRESUMEN
This work aims at examining the effect of the concentrated methanol extract of Rubus croceacanthus Leveille (RCL) on mast cell-mediated anaphylactic-like reaction in a murine model. RCL inhibited compound 48/80-induced systemic anaphylactic-like reaction. When RCL was given as pre-treatment at concentrations ranging from 0.01 to 1 mg/ml, the histamine release from rat peritoneal mast cells induced by compound 48/80 or anti-dinitrophenyl (DNP) immunoglobulin E (IgE) was reduced in a dose-dependent manner. RCL also inhibited passive cutaneous anaphylaxis activated by anti-DNP IgE. In addition, RCL inhibited phorbol 12-myristate 13-acetate and A23187-induced tumor necrosis factor-alpha secretion from human mast cell line HMC-1 cells. These results indicate that RCL may possess a strong anti-anaphylactic activity.
Asunto(s)
Mastocitos/efectos de los fármacos , Extractos Vegetales/farmacología , Rosaceae/química , Factor de Necrosis Tumoral alfa/metabolismo , Anafilaxia/inducido químicamente , Anafilaxia/tratamiento farmacológico , Anafilaxia/prevención & control , Animales , Línea Celular , Histamina/metabolismo , Humanos , Masculino , Mastocitos/inmunología , Ratones , Ratones Endogámicos ICR , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Ratas , Ratas Wistar , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidoresRESUMEN
We studied the effect of aqueous extract of Magnolia officinalis bark (Magnoliaceae) (MOAE) on the immediate hypersensitivity reaction. MOAE (0.01 to 1 g/kg) dose-dependently inhibited compound 48/80 induced systemic anaphylaxis in rats. MOAE (0.1 and 1 g/kg) also significantly inhibited local immunoglobulin E (IgE)-mediated passive cutaneous anaphylactic reaction. When MOAE was pretreated at concentrations ranging from 0.01 to 1 g/kg, the levels of plasma histamine were reduced in a dose-dependent manner. MOAE (0.001 to 1 mg/ml) dose-dependently inhibited the histamine release from rat peritoneal mast cells (RPMC) activated by compound 48/80 or anti-dinitrophenyl (DNP) IgE. The level of cyclic AMP (cAMP) in RPMC, when MOAE was added, significantly increased compared with that of the normal control. Moreover, MOAE (0.01 to 1 mg/ml) had a significant inhibitory effect on anti-DNP IgE-induced tumor necrosis factor-alpha production from RPMC. These results indicate that MOAE inhibits immediate hypersensitivity reaction in vivo and in vitro.
Asunto(s)
Antialérgicos/uso terapéutico , Hipersensibilidad Inmediata/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Plantas Medicinales/química , Animales , AMP Cíclico/biosíntesis , Liberación de Histamina/efectos de los fármacos , Indicadores y Reactivos , Masculino , Mastocitos/efectos de los fármacos , Mastocitos/metabolismo , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/biosíntesis , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
This report describes an inhibitory effect of Gahmi-Shini-San (GSS) on mast cell-mediated immediate-type allergic reactions. GSS is an Oriental herbal medication, which has been successfully used in Korea for the treatment of allergic disorders, mainly skin anaphylactic diseases. GSS inhibited the ear swelling response induced by intradermal injection of compound 48/80 in a mouse model on a concentration-dependent basis. The mast cells in mouse ear tissue were stained by alcian blue/nuclear fast red. GSS significantly inhibited the compound 48/80-induced degranulation from mast cells in ear tissue. GSS dose-dependently inhibited the histamine release from the rat peritoneal mast cells by compound 48/80. We also studied the effect of GSS on mast cell-dependent passive cutaneous anaphylaxis activated by dinitrophenyl IgE antibody. GSS showed inhibition of passive cutaneous anaphylaxis following oral administration. These results indicated that GSS has inhibitory effect on mast cell-dependent immediate type cutaneous reactions.
Asunto(s)
Degranulación de la Célula/efectos de los fármacos , Histamina/metabolismo , Hipersensibilidad/fisiopatología , Mastocitos/metabolismo , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Extractos Vegetales/farmacología , Azul Alcián/análisis , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Oído/fisiopatología , Hipersensibilidad/tratamiento farmacológico , Mastocitos/citología , Ratones , Rojo Neutro/análisis , Anafilaxis Cutánea Pasiva/fisiología , Cavidad Peritoneal/citología , Ratas , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidoresRESUMEN
We investigated the effect of water extract of Solanum melongena(SMWE) on immunologic and nonimmunologic stimulation-mediated anaphylactic reactions. Nonimmunologic anaphylactic reaction was induced by compound 48/80 injection. Oral administration of SMWE (1 g kg(-1)) completely inhibited compound 48/80-induced anaphylactic reaction. Immunologic anaphylactic reaction was generated by sensitizing the skin with anti-dinitrophenyl (DNP) IgE followed 48 h later with an injection of antigen. Oral administration of SMWE (0.01--1 g kg(-1)) significantly inhibited passive cutaneous anaphylactic reaction activated by anti-DNP IgE to between 83.10 +/- 1.67% and 70.17 +/- 2.17%. SMWE (0.01--1 mg ml(-1)) also inhibited histamine release activated by compound 48/80 to between 93 +/- 2.65 and 70 +/- 1.50%. Moreover, SMWE (0.01--1 mg ml(-1)) had a significant inhibitory effect on IgE-induced tumor necrosis factor (TNF)-alpha secretion from rat peritoneal mast cells. These results indicate that SMWE inhibits immunologic and nonimmunologic stimulation-mediated anaphylactic reactions and TNF-alpha secretion from mast cells.
Asunto(s)
Anafilaxia/tratamiento farmacológico , Anafilaxia/inmunología , Factores Biológicos/farmacología , Factores Biológicos/uso terapéutico , Magnoliopsida/química , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Administración Oral , Anafilaxia/inducido químicamente , Animales , Factores Biológicos/administración & dosificación , Dinitrofenoles/inmunología , Modelos Animales de Enfermedad , Histamina/metabolismo , Inmunoglobulina E/inmunología , Mastocitos/metabolismo , Ratones , Ratones Endogámicos ICR , Ratas , Factor de Necrosis Tumoral alfa/metabolismo , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
We investigated the effect of an aqueous extract of Schizonepeta tenuifolia (STAE) on mast cell-mediated immediate-type hypersensitivity. STAE inhibited systemic allergic reaction induced by compound 48/80 in rats dose-dependently. STAE also inhibited plasma histamine levels induced by compound 48/80. STAE inhibited local allergic reaction activated by anti-dinitrophenyl (DNP) IgE. In addition, STAE does-dependently inhibited histamine release from rat peritoneal mast cells (RPMC) activated by compound 48/80 or anti-DNP IgE. However, STAE had a significant enhancing effect on anti-DNP IgE-induced tumor necrosis factor-alpha (TNF-alpha) production from RPMC. These results indicate that STAE inhibits immediate-type hypersensitivity and suggest that STAE can selectively activate the TNF-alpha production from RPMC.
Asunto(s)
Anafilaxia/inmunología , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Plantas Medicinales/química , Anafilaxia/tratamiento farmacológico , Anafilaxia/prevención & control , Animales , Dinitrofenoles/inmunología , Relación Dosis-Respuesta Inmunológica , Liberación de Histamina/efectos de los fármacos , Inmunoglobulina E/inmunología , Lamiaceae/química , Mastocitos/metabolismo , Cavidad Peritoneal/citología , Extractos Vegetales/farmacología , Ratas , Ratas Wistar , Factor de Necrosis Tumoral alfa/biosíntesis , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/inmunologíaRESUMEN
Shini-San has been used for treatment of allergic disease in Korea. However, its effect in experimental models remains unknown. The mast cell plays a pivotal role in initiating allergic response by secreting intracytoplasmic granular mediators such as histamine. The present report describes an inhibitory effect of Shini-San on mast cell-mediated immediate-type allergic reactions. Topical application of compound 48/80 can induce an ear swelling response in normal (WBB6F1(-)+/+) mice but not in congenic mast cell-deficient WBB6F1-W/WV mice. Shini-San inhibited concentration-dependent mast cell-dependent ear swelling response induced by compound 48/80 in normal mice. Shini-San inhibited concentration-dependent passive cutaneous anaphylaxis induced by anti-dinitrophenyl (DNP) immunoglobulin E (IgE) in rats by topical application. Shini-San also inhibited in concentration-dependent fashion the histamine release from the rat peritoneal mast cells by compound 48/80 or anti-DNP IgE. Moreover, Shini-San had a significant inhibitory effect on compound 48/80-induced systemic anaphylactic reaction. These results indicate that Shini-San inhibits immediate type allergic reactions by inhibition of mast cell degranulation in vivo and in vitro.
Asunto(s)
Antialérgicos/farmacología , Hipersensibilidad Inmediata/tratamiento farmacológico , Mastocitos/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Edema/inducido químicamente , Edema/prevención & control , Liberación de Histamina/efectos de los fármacos , Hipersensibilidad Inmediata/inmunología , Hipersensibilidad Inmediata/metabolismo , Masculino , Mastocitos/metabolismo , Ratones , Ratones Endogámicos C57BL , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Preparaciones Farmacéuticas , Ratas , Ratas Wistar , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
We investigated the effect of aqueous extract of Rehmannia glutinosa steamed root (RGAE) on the allergic reactions in vivo and in vitro. RGAE dose-dependently inhibited systemic allergic reaction induced by compound 48/80. When RGAE was pre-treated at the same concentrations with systemic allergic reaction test, the plasma histamine levels were reduced in a dose-dependent manner. RGAE dose-dependently inhibited skin allergic reaction activated by anti-dinitrophenyl (DNP) IgE. RGAE also dose-dependently inhibited the histamine release from the rat peritoneal mast cells (RPMC) by compound 48/80 or anti-DNP IgE. Moreover, RGAE had significant inhibitory effect on anti-DNP IgE-induced tumor necrosis factor-alpha production of RPMC. These results indicate that RGAE may be beneficial in the regulation of immediate type allergic reaction.
Asunto(s)
Hipersensibilidad Inmediata/tratamiento farmacológico , Plantas Medicinales/química , 2,4-Dinitrofenol/antagonistas & inhibidores , 2,4-Dinitrofenol/farmacología , Animales , Relación Dosis-Respuesta a Droga , Histamina/sangre , Liberación de Histamina/efectos de los fármacos , Hipersensibilidad Inmediata/inmunología , Mastocitos/efectos de los fármacos , Mastocitos/metabolismo , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Factor de Necrosis Tumoral alfa/farmacología , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
1. The effect of the pigment obtained from the stem and leaf of Polygonum tinctorium Loar (PtP) on anaphylactic reactions was studied in rats. 2. PtP totally inhibited compound 48/80-induced anaphylactic shock with doses of 10(2) and 10(3) mg/ kg. When PtP was pretreated at concentrations ranging from 10(-2) to 10(3) mg/kg, the serum histamine levels induced by compound 48/80 were reduced in a dose-dependent manner. 3. We also investigated the effect of PtP on mast cell-dependent passive cutaneous anaphylaxis (PCA) activated by anti-dinitrophenyl (DNP) IgE antibody. PtP potently inhibited PCA when administered orally, topically, intraperitoneally and intradermally. However, it did not show inhibitory activity when administered intravenously. 4. PtP inhibited dose dependently histamine release from rat peritoneal mast cells (RPMCs) induced by compound 48/80 and anti-DNP IgE. Moreover, the level of cAMP in RPMC, when PtP was added, significantly increased about 12-fold at 4 min compared with that of basal cells. 5. These results indicate that PtP may possess strong antianaphylactic activity and suggest that differences in bioavailability may cause differential activity following different administration routes.
Asunto(s)
Anafilaxia/prevención & control , Medicamentos Herbarios Chinos/farmacología , Mastocitos/efectos de los fármacos , Pigmentos Biológicos/farmacología , Polygonaceae/química , Anafilaxia/inducido químicamente , Animales , AMP Cíclico/metabolismo , Femenino , Liberación de Histamina/efectos de los fármacos , Inmunoglobulina E , Masculino , Mastocitos/fisiología , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Pigmentos Biológicos/uso terapéutico , Plantas Medicinales , Ratas , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidores , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
The sesquiterpene lactones isolated from Geigeria were found to be incapable of inducing rat peritoneal mast cell degranulation at levels of 0.3-1.6 mM. The sulphydryl reagent, N-ethylmaleimide, too was unable to trigger mast cell secretion. Instead, it was observed that these compounds inhibited the release of histamine induced by Compound 48/80. Pretreatment of the lactones and N-ethylmaleimide with the amino acid, L-cysteine, reduced their inhibition ability of histamine release to a considerable extent, but not completely. Geigerin(V), which lacks an alpha-methylene group and the chemically prepared cysteine-adduct of dihydrogriesenin(I), were also capable of inhibiting mast cell secretion by Compound 48/80, but to a lesser extent.
Asunto(s)
Lactonas/farmacología , Mastocitos/efectos de los fármacos , Extractos Vegetales/farmacología , Sesquiterpenos/farmacología , Alquilación , Animales , Cisteína/farmacología , Etilmaleimida/farmacología , Liberación de Histamina/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas , Sesquiterpenos de Guayano , Tapsigargina , p-Metoxi-N-metilfenetilamina/antagonistas & inhibidoresRESUMEN
Rat peritoneal mast cells incubated with a histamine liberator, compound 48/80, showed a significantly reduced capacity for releasing histamine following in vitro treatment with 0.1 micrograms/ml of 8-methoxypsoralen (8-MOP) plus 1-5 J/cm2 of long-wave ultraviolet (UVA) irradiation (PUVA). No remarkable inhibition in histamine release was observed in the cells treated with 8-MOP only. Irradiation with 5 J/cm2 of UVA alone exerted an inhibitory effect on histamine release, to a lesser extent than PUVA. PUVA irradiation did not bring any decrease in cell viability or any spontaneous release of histamine from irradiated cells as shown by phase-contrast microscopy and by histamine assay, respectively. These results suggest that PUVA treatment may cause a noncytotoxic disturbance at mast cell membranes or on surface receptors, leading to a decreased capacity for secreting chemical mediators.